Latest Insider Transactions at Alphatec Holdings, Inc. (ATEC)
This section provides a real-time view of insider transactions for Alphatec Holdings, Inc. (ATEC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alphatec Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alphatec Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,000
+25.85%
|
$33,000
$11.66 P/Share
|
|
Dec 10
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+2.43%
|
$11,000
$11.79 P/Share
|
|
Dec 09
2021
|
James L L Tullis |
SELL
Open market or private sale
|
Indirect |
20,000
-3.66%
|
$220,000
$11.78 P/Share
|
|
Dec 09
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+2.49%
|
$12,000
$12.18 P/Share
|
|
Dec 02
2021
|
Patrick Miles CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
57,443
-1.13%
|
$574,430
$10.7 P/Share
|
|
Nov 26
2021
|
Evan Bakst |
BUY
Open market or private purchase
|
Direct |
10,000
+1.26%
|
$100,000
$10.57 P/Share
|
|
Nov 24
2021
|
Paul Segal |
BUY
Open market or private purchase
|
Direct |
100,000
+37.38%
|
$1,100,000
$11.17 P/Share
|
|
Nov 23
2021
|
Paul Segal |
BUY
Open market or private purchase
|
Direct |
67,496
+50.0%
|
$674,960
$10.09 P/Share
|
|
Nov 23
2021
|
Jason Hochberg Director |
BUY
Open market or private purchase
|
Direct |
5,000
+5.93%
|
$50,000
$10.83 P/Share
|
|
Nov 16
2021
|
David H Mowry |
SELL
Open market or private sale
|
Direct |
14,254
-15.48%
|
$171,048
$12.25 P/Share
|
|
Nov 12
2021
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
BUY
Open market or private purchase
|
Direct |
15,000
+1.4%
|
$165,000
$11.66 P/Share
|
|
Nov 12
2021
|
David Sponsel EVP, SALES |
SELL
Open market or private sale
|
Direct |
9,847
-1.79%
|
$108,317
$11.56 P/Share
|
|
Nov 11
2021
|
David R Pelizzon |
BUY
Open market or private purchase
|
Direct |
4,366
+1.49%
|
$48,026
$11.41 P/Share
|
|
Nov 11
2021
|
Patrick Miles CEO |
BUY
Open market or private purchase
|
Direct |
50,000
+0.97%
|
$550,000
$11.71 P/Share
|
|
Nov 10
2021
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
6,250
-2.3%
|
$68,750
$11.79 P/Share
|
|
Nov 08
2021
|
David R Pelizzon |
BUY
Open market or private purchase
|
Direct |
5,425
+1.87%
|
$70,525
$13.0 P/Share
|
|
Aug 27
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,000
+33.33%
|
$26,000
$13.26 P/Share
|
|
Aug 17
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
554
+25.35%
|
$6,648
$12.62 P/Share
|
|
Aug 13
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,077
+50.0%
|
$12,924
$12.99 P/Share
|
|
Aug 12
2021
|
Elizabeth Ann Altman |
BUY
Grant, award, or other acquisition
|
Direct |
29,894
+45.64%
|
-
|
|
Aug 11
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+2.55%
|
$13,000
$13.13 P/Share
|
|
Aug 09
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,000
+0.11%
|
$42,000
$14.69 P/Share
|
|
Aug 09
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,000
+2.62%
|
$14,000
$14.68 P/Share
|
|
Aug 06
2021
|
Patrick Miles CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+4.71%
|
$500,000
$2.0 P/Share
|
|
Aug 05
2021
|
Kelli Mari Howell EVP, CLINICAL STRATEGIES |
SELL
Payment of exercise price or tax liability
|
Direct |
6,050
-1.22%
|
$90,750
$15.23 P/Share
|
|
Aug 05
2021
|
Brian Snider EVP, MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct |
6,324
-1.02%
|
$94,860
$15.23 P/Share
|
|
Aug 05
2021
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Payment of exercise price or tax liability
|
Direct |
9,760
-0.93%
|
$146,400
$15.23 P/Share
|
|
Aug 05
2021
|
David Sponsel EVP, SALES |
SELL
Payment of exercise price or tax liability
|
Direct |
620
-0.11%
|
$9,300
$15.23 P/Share
|
|
Aug 03
2021
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-3.35%
|
$140,000
$14.24 P/Share
|
|
Jul 12
2021
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
11,965
-3.86%
|
$191,440
$16.46 P/Share
|
|
Jul 01
2021
|
Patrick Miles CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
154,938
-3.12%
|
$2,324,070
$15.32 P/Share
|
|
Jul 01
2021
|
David Sponsel EVP, SALES |
SELL
Payment of exercise price or tax liability
|
Direct |
3,099
-0.56%
|
$46,485
$15.32 P/Share
|
|
Jun 17
2021
|
Marie Meynadier |
BUY
Grant, award, or other acquisition
|
Direct |
30,672
+45.01%
|
-
|
|
Jun 16
2021
|
James L L Tullis |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+6.11%
|
-
|
|
Jun 16
2021
|
Evan Bakst |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+1.3%
|
-
|
|
Jun 16
2021
|
Quentin S. Blackford |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+1.91%
|
-
|
|
Jun 16
2021
|
Jason Hochberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+12.08%
|
-
|
|
Jun 16
2021
|
Karen K Mcginnis |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+16.79%
|
-
|
|
Jun 16
2021
|
David H Mowry |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+9.99%
|
-
|
|
Jun 16
2021
|
Jeffrey P Rydin |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+2.35%
|
-
|
|
Jun 16
2021
|
Ward W Woods Jr |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+9.81%
|
-
|
|
Jun 16
2021
|
Donald Allen Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+7.05%
|
-
|
|
Jun 16
2021
|
David Sponsel EVP, SALES |
SELL
Open market or private sale
|
Direct |
10,000
-1.77%
|
$140,000
$14.78 P/Share
|
|
Jun 16
2021
|
David R Pelizzon |
BUY
Grant, award, or other acquisition
|
Direct |
10,221
+3.53%
|
-
|
|
Jun 16
2021
|
L 5 Healthcare Partners, LLC |
SELL
Payment of exercise price or tax liability
|
Direct |
93,747
-1.12%
|
$1,312,458
$14.93 P/Share
|
|
Jun 16
2021
|
L 5 Healthcare Partners, LLC |
BUY
Exercise of conversion of derivative security
|
Direct |
400,000
+4.58%
|
$1,200,000
$3.5 P/Share
|
|
May 17
2021
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Payment of exercise price or tax liability
|
Direct |
28,271
-2.62%
|
$395,794
$14.81 P/Share
|
|
May 17
2021
|
David Sponsel EVP, SALES |
BUY
Payment of exercise price or tax liability
|
Direct |
34,087
+5.7%
|
$477,218
$14.81 P/Share
|
|
May 17
2021
|
Kelli Mari Howell EVP, CLINICAL STRATEGIES |
SELL
Payment of exercise price or tax liability
|
Direct |
17,525
-3.4%
|
$245,350
$14.81 P/Share
|
|
May 17
2021
|
Brian Snider EVP, MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct |
21,982
-3.43%
|
$307,748
$14.81 P/Share
|